Drugs / Tenoten for children
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials · 2 met primary | ||||||
| Phase 3 | NCT03159611 | Feb 2016 → Feb 2018 | brain injury | Materia Medica Holding | Completed | Met primary |
| Phase 3 | NCT03159104 | Aug 2015 → Feb 2019 | specific learning disability | Materia Medica Holding | Completed | Met primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT05605938 | Jul 2010 → Oct 2011 | anxiety disorder | Materia Medica Holding | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tenoten for children | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03159611 ↗ |
| Route | Oral | “Tablet for oral use.” NCT03159104 ↗ |